Verisk’s Tobacco Usage Propensity Model offers the life industry a two-prong solution: It can assist in substantially reducing the number of lab tests insurers order in the underwriting process, while simultaneously helping tackle the $10 billion problem of smoker nondisclosure.
Verisk Sponsored Content
